Cellames Inc is an innovative bioelectronics technology company that develops MEA (Micro Electrode Array) systems
one for impedance measurement to non-destructively monitor cell proliferation, differentiation, death, toxicity,
and drug effects in real time, and another for local field potential measurement to capture electrophysiological signals
of cardiac muscle cells and nerve cells to identify and analyze cell drug toxicity responses.
We have developed a disk electrode array plate that is easy to observe under a microscope using transparent disk electrodes,
providing a useful tool for cell research and analysis. In particular, we are developing a system that can overcome
ethical issues and interspecies differences by conducting toxicity and efficacy evaluations of new drug development
and test substances using human induced pluripotent stem cells (HiPSCs) rather than animals.
This system can be applied to animal replacement testing methods, and we hope to contribute to the development of human
society through this.